2 completed, 1 withdrawn. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Oriol Mitja: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea Combination regimen: Fluoxetine, Prednisolone, Ivermectin, Combination regimen: Albendazole, Vitamin C - SARS-CoV2 Infection, COVID-19 | Phase 2 / Phase 3 | Withdrawn | Oriol Mitja | 2022-05-01 | 2023-03-09 | |
| An Accessible Low-cost Plant Treatment for Cutaneous Ulcers Topical antiseptic treatment - Yaws; Cutaneous, Cutaneous Ulcer | Phase 2 | Completed | Oriol Mitja | 150 | 2019-11-01 | 2020-09-03 |
| Dual Point-of-care Test for the Diagnosis of Yaws Yaws | Completed | Oriol Mitja | 703 | 2013-04-01 | 2014-11-18 |
Yaws (2) · COVID-19 (1) · Disease (1) · Skin Ulcer (1)
Ascorbic Acid (1) · Ivermectin (1) · Prednisolone (1)
Papua New Guinea (2)